Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
To enhance targeting efficacy in the radioimmunotherapy of disseminated cancer, several pretargeting strategies have been developed. In pretargeted radioimmunotherapy, the tumor is pretargeted with a modified monoclonal antibody that has an affinity for both tumor antigens and radiolabeled carriers....
Saved in:
Main Authors: | Chiara Timperanza (Author), Holger Jensen (Author), Tom Bäck (Author), Sture Lindegren (Author), Emma Aneheim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211
by: Chiara Timperanza, et al.
Published: (2024) -
Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy
by: Chiara Timperanza, et al.
Published: (2024) -
Astatine-211 radiolabelling chemistry: from basics to advanced biological applications
by: Maarten Vanermen, et al.
Published: (2024) -
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
by: Xuhao Huang, et al.
Published: (2022) -
The Different Strategies for the Radiolabeling of [<sup>211</sup>At]-Astatinated Radiopharmaceuticals
by: Jie Gao, et al.
Published: (2024)